trans-2-pentenoic acid

Names

[ CAS No. ]:
13991-37-2

[ Name ]:
trans-2-pentenoic acid

[Synonym ]:
(E)-Pent-2-enoic acid
MFCD00002704
TRANS-2-PENTENOIC ACID
EINECS 237-791-9

Chemical & Physical Properties

[ Density]:
0.99 g/mL at 25 °C(lit.)

[ Boiling Point ]:
106 °C20 mm Hg(lit.)

[ Melting Point ]:
9-11 °C(lit.)

[ Molecular Formula ]:
C₅H₈O₂

[ Molecular Weight ]:
100.11600

[ Flash Point ]:
102 °C

[ Exact Mass ]:
100.05200

[ PSA ]:
37.30000

[ LogP ]:
1.03720

[ Vapour Pressure ]:
0.107mmHg at 25°C

[ Index of Refraction ]:
n20/D 1.452(lit.)

MSDS

Safety Information

[ Symbol ]:

GHS05, GHS07

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H302-H314

[ Precautionary Statements ]:
P280-P305 + P351 + P338-P310

[ Personal Protective Equipment ]:
Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
C: Corrosive;

[ Risk Phrases ]:
R22;R34

[ Safety Phrases ]:
S26-S36/37/39-S45

[ RIDADR ]:
UN 3265 8/PG 3

[ WGK Germany ]:
3

[ RTECS ]:
SB2750000

[ Packaging Group ]:
III

[ Hazard Class ]:
8

Synthetic Route

Click to get detail synthetic route

Articles

Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs.

FASEB J. 26 , 4951-65, (2012)

When it is difficult to develop selective ligands within a family of related G-protein-coupled receptors (GPCRs), chemically engineered receptors activated solely by synthetic ligands (RASSLs) are use...

Structure-activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR109A).

Bioorg. Med. Chem. Lett. 21 , 2736-9, (2011)

Nicotinic acid (niacin) has been used for decades as an antidyslipidemic drug in man. Its main target is the hydroxy-carboxylic acid receptor HCA2 (GPR109A), a G protein-coupled receptor. Other acids ...

Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone.

Bioorg. Med. Chem. Lett. 9(7) , 1009-12, (1999)

New nonsteroidal human androgen receptor (hAR) agonists were developed from an hAR antagonist pharmacophore, 2(1H)-piperidino[3,2-g]quinolinone. (+/-)-trans-7,8-Diethyl-4-trifluoromethyl-2(H)-piperidi...

trans-5-iodo-2-pentenoic acid
(Z)-2-Pentenoic acid ethyl ester
(2E)-2-pentenoic acid tert-butyl ester
(E)-2-pentenoic acid
(2E)-2-Methyl-2-pentenoic acid
(E)- 4-oxopent-2-enoic acid
N1-(5-methylisoxazol-3-yl)-N2-(pyridin-4-ylmethyl)oxalamide
2-benzyl-8,9-dimethyl-7-(4-methyl-2-pyridinyl)-7H-pyrrolo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine
2-{[1-(3-chlorophenyl)-5,5-dioxido-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-2-yl]sulfanyl}-N,N-dimethylacetamide
4-{[3-(4-Fluorophenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]amino}benzamide
N-{2-[1-(furan-2-carbonyl)-5-(2-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl}methanesulfonamide
2-[1-(naphthalen-2-ylsulfonyl)pyrrolidin-2-yl]-1H-benzimidazole
N-(4-bromophenyl)-2-[(2S,11aS)-2-hydroxy-5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]acetamide
5-bromo-N~3~-[2-(5-fluoro-1H-indol-3-yl)ethyl]nicotinamide
N-(butan-2-yl)-5-chloro-2-(methylsulfonyl)pyrimidine-4-carboxamide
4-[4-oxo-1,2,3-benzotriazin-3(4H)-yl]-N~1~-(4-pyridylmethyl)butanamide

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.